These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. [Role of mitochondrial dysfunction in non-alcoholic steatohepatitis]. Elloumi H; Arfaoui D; Nabli N; Ajmi S Tunis Med; 2003 Oct; 81(10):763-7. PubMed ID: 17722791 [TBL] [Abstract][Full Text] [Related]
46. Medical treatment of non-alcoholic steatohepatitis. Kadayifci A; Merriman RB; Bass NM Clin Liver Dis; 2007 Feb; 11(1):119-40, ix. PubMed ID: 17544975 [TBL] [Abstract][Full Text] [Related]
47. [Definition and management of non-alcoholic steatohepatitis (NASH)]. Hütteroth TH Dtsch Med Wochenschr; 2001 Jun; 126 Suppl 1():S64-7. PubMed ID: 11450617 [No Abstract] [Full Text] [Related]
48. Invasive and non-invasive investigations for non-alcoholic steatohepatitis (NASH): the need for biochemical markers. Ahmed MH Scand J Gastroenterol; 2006 Mar; 41(3):372. PubMed ID: 16497631 [No Abstract] [Full Text] [Related]
49. Imaging of hepatic steatosis and fatty sparing. Karcaaltincaba M; Akhan O Eur J Radiol; 2007 Jan; 61(1):33-43. PubMed ID: 17118603 [TBL] [Abstract][Full Text] [Related]
50. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Younossi ZM Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557 [TBL] [Abstract][Full Text] [Related]
52. High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease. Kantartzis K; Thamer C; Peter A; Machann J; Schick F; Schraml C; Königsrainer A; Königsrainer I; Kröber S; Niess A; Fritsche A; Häring HU; Stefan N Gut; 2009 Sep; 58(9):1281-8. PubMed ID: 19074179 [TBL] [Abstract][Full Text] [Related]
53. Non-alcoholic steatohepatitis in children and adolescents. Manton ND; Lipsett J; Moore DJ; Davidson GP; Bourne AJ; Couper RT Med J Aust; 2000 Nov; 173(9):476-9. PubMed ID: 11149304 [TBL] [Abstract][Full Text] [Related]
54. [Non-alcoholic fatty liver disease--new view]. Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346 [TBL] [Abstract][Full Text] [Related]
56. Significant non-alcoholic fatty liver disease is found in non-diabetic, pre-obese Chinese in Singapore. Chow WC; Tai ES; Lian SC; Tan CK; Sng I; Ng HS Singapore Med J; 2007 Aug; 48(8):752-7. PubMed ID: 17657385 [TBL] [Abstract][Full Text] [Related]
57. Diagnostic imaging of the fatty liver. Sotile SC; Brogdon BG; Melhem RE Ala J Med Sci; 1988 Oct; 25(4):412-6. PubMed ID: 3064622 [No Abstract] [Full Text] [Related]
58. [Non-alcoholic steatohepatitis: a controversial cause of liver cirrhosis]. Guilarte López-Mañas J; Bellot García V; Gil Villa MM Gastroenterol Hepatol; 1997 Apr; 20(4):217. PubMed ID: 9280618 [No Abstract] [Full Text] [Related]
59. [The therapeutic effect of metadoxine on alcoholic and non-alcoholic steatohepatitis]. Váli L; Blázovics A; Fehér J Orv Hetil; 2005 Nov; 146(47):2409-14. PubMed ID: 16398154 [TBL] [Abstract][Full Text] [Related]
60. Imaging diagnosis and quantification of hepatic steatosis: is it an accepted alternative to needle biopsy? Lupsor M; Badea R Rom J Gastroenterol; 2005 Dec; 14(4):419-25. PubMed ID: 16400362 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]